<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Par panel asks govt to enhance domestic output of P&amp;K fertilisers, cut imports</title>
    <link>https://www.taxtmi.com/news?id=63294</link>
    <description>Parliamentary panel urges strengthening domestic production of phosphatic and potassic (P&amp;K) fertilisers to reduce import dependence, noting domestic capacity (160 lakh tonnes) is insufficient against demand (240 lakh tonnes) and projected consumption (305 lakh tonnes by 2035-36). The Committee cites global price volatility, exchange rate movements and supply chain disruptions as risks to costs and directs the Department of Fertilisers to ensure timely completion of projects and capacity expansion. Separately, it recommends that the National Pharmaceutical Pricing Authority and the Department of Pharmaceuticals act to reduce stent prices and enforce price limits to prevent overcharging.</description>
    <language>en-us</language>
    <pubDate>Mon, 01 Dec 2025 23:16:03 +0530</pubDate>
    <lastBuildDate>Mon, 01 Dec 2025 23:16:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=868450" rel="self" type="application/rss+xml"/>
    <item>
      <title>Par panel asks govt to enhance domestic output of P&amp;K fertilisers, cut imports</title>
      <link>https://www.taxtmi.com/news?id=63294</link>
      <description>Parliamentary panel urges strengthening domestic production of phosphatic and potassic (P&amp;K) fertilisers to reduce import dependence, noting domestic capacity (160 lakh tonnes) is insufficient against demand (240 lakh tonnes) and projected consumption (305 lakh tonnes by 2035-36). The Committee cites global price volatility, exchange rate movements and supply chain disruptions as risks to costs and directs the Department of Fertilisers to ensure timely completion of projects and capacity expansion. Separately, it recommends that the National Pharmaceutical Pricing Authority and the Department of Pharmaceuticals act to reduce stent prices and enforce price limits to prevent overcharging.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Mon, 01 Dec 2025 23:16:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=63294</guid>
    </item>
  </channel>
</rss>